MedImmune President Peter Greenleaf will chair a new authority that will oversee investments state government makes in technology startup companies.
Greenleaf was one of nine members of the Maryland Venture Fund Authority sworn in Wednesday. The group was created in anticipation of about $18 million coming into the fund via the state’s developing InvestMaryland program.
Gov. Martin O’Malley signed InvestMaryland into law in May. The program auctions off tax breaks to insurance companies and provides that money to private venture capitalists and the state venture fund to invest in startups based in Maryland.
To read the full, original article click on this link: MedImmune president to head Maryland venture capital board - Washington Business Journal
Author:Scott Dance
